OPM’s OsteoFab PEKK material will be used in new 3D-printed interbody implants from VySpine, according to a Feb. 22 news release. OsteoFab technology includes antibacterial and antiviral properties, metal and metallosis-free formulation and radiolucency.
“OPM has a history of developing industry partnerships with companies dedicated to innovative solutions that push medical device technology forward in ways that improve patient outcomes,” OPM founder and CEO Scott DeFelice said in the release. “VySpine clearly fits that mold.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
